The Concurrent Treatment With Intravenous Ketamine and an Irreversible Monoamine Oxidase Inhibitor for Treatment-Resistant Depression Without Hypertensive Crises

Oxidase Inhibitor ◽

Treatment Resistant ◽

Concurrent Treatment ◽

Resistant Depression ◽

Hypertensive Crises ◽

The Monoamine Oxidase Inhibitor Isocarboxazid is a Relevant Treatment Option in Treatment-Resistant Depression-Experience-Based Strategies in Danish Psychiatry

Health Care Current Reviews ◽

10.4172/2375-4273.1000168 ◽

2016 ◽

Vol 4 (2) ◽

Cited By ~ 1

Author(s):

Jens Knud Larsen ◽

Lene Krogh Nielsen

Keyword(s):

Monoamine Oxidase ◽

Treatment Option ◽

Oxidase Inhibitor ◽

Treatment Resistant ◽

Relative effectiveness of tricyclic antidepressant versus monoamine oxidase inhibitor monotherapy for treatment-resistant depression

Journal of Affective Disorders ◽

10.1016/j.jad.2019.03.028 ◽

2019 ◽

Vol 250 ◽

pp. 199-203 ◽

Cited By ~ 2

Author(s):

Thomas Kim ◽

Colin Xu ◽

Jay D. Amsterdam

Keyword(s):

Monoamine Oxidase ◽

Relative Effectiveness ◽

Oxidase Inhibitor ◽

Tricyclic Antidepressant ◽

Treatment Resistant ◽

Modafinil Enhances Two-Year Outcome from Monoamine Oxidase Inhibitor Therapy in 3 Patients with Treatment-Resistant Depression

Advances in Pharmacoepidemiology & Drug Safety ◽

10.4172/2167-1052.1000189 ◽

2015 ◽

Vol 04 (04) ◽

Keyword(s):

Monoamine Oxidase ◽

Oxidase Inhibitor ◽

Inhibitor Therapy ◽

Treatment Resistant ◽

F170. Monoamine Oxidase Inhibitor Use in an Adult Patient With Treatment Resistant Depression

Biological Psychiatry ◽

10.1016/j.biopsych.2018.02.784 ◽

2018 ◽

Vol 83 (9) ◽

pp. S304 ◽

Cited By ~ 1

Author(s):

Lorie Shora ◽

Carlos Zarate ◽

Lawrence Park ◽

Melbaliz Velez Afanador

Keyword(s):

Monoamine Oxidase ◽

Adult Patient ◽

Oxidase Inhibitor ◽

Treatment Resistant ◽

Safety of High-intensity Treatment with the Irreversible Monoamine Oxidase Inhibitor Tranylcypromine in Patients with Treatment-resistant Depression

Pharmacopsychiatry ◽

10.1055/s-0028-1083819 ◽

2008 ◽

Vol 41 (06) ◽

pp. 252-257 ◽

Cited By ~ 28

Author(s):

M. Adli ◽

M. Pilhatsch ◽

M. Bauer ◽

U. Köberle ◽

R. Ricken ◽

...

Keyword(s):

Monoamine Oxidase ◽

High Intensity ◽

Oxidase Inhibitor ◽

Treatment Resistant ◽

Relative Effectiveness of Monoamine Oxidase Inhibitor and Tricyclic Antidepressant Combination Therapy for Treatment-Resistant Depression

Journal of Clinical Psychopharmacology ◽

10.1097/jcp.0000000000001130 ◽

2019 ◽

Vol 39 (6) ◽

pp. 649-652

Author(s):

Jay D. Amsterdam ◽

Thomas T. Kim

Keyword(s):

Combination Therapy ◽

Monoamine Oxidase ◽

Relative Effectiveness ◽

Oxidase Inhibitor ◽

Tricyclic Antidepressant ◽

Treatment Resistant ◽

Resistant Depression ◽

Antidepressant Combination

Faculty Opinions recommendation of Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.2203956.1814054 ◽

2010 ◽

Author(s):

Randal Dull ◽

Scott Tadler

Keyword(s):

Repeated Dose ◽

Treatment Resistant ◽

Safety And Efficacy ◽

Resistant Depression ◽

Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case Series

American Journal of Geriatric Psychiatry ◽

10.1016/j.jagp.2020.12.032 ◽

2021 ◽

Author(s):

Orly Lipsitz ◽

Joshua D. Di Vincenzo ◽

Nelson B. Rodrigues ◽

Danielle S. Cha ◽

Yena Lee ◽

...

Keyword(s):

Older Adults ◽

Real World ◽

Case Series ◽

Treatment Resistant ◽

Resistant Depression ◽

Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trial

Neuropsychopharmacology ◽

10.1038/s41386-021-01242-9 ◽

2021 ◽

Author(s):

Marijn Lijffijt ◽

Nicholas Murphy ◽

Sidra Iqbal ◽

Charles E. Green ◽

Tabish Iqbal ◽

...

Keyword(s):

Late Life ◽

Optimal Dose ◽

Treatment Resistant ◽

Adaptive Randomization ◽

Resistant Depression ◽

Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial

The International Journal of Neuropsychopharmacology ◽

10.1017/s1461145709000169 ◽

2010 ◽

Vol 13 (1) ◽

pp. 71-82 ◽

Cited By ~ 165

Author(s):

Sanjay J. Mathew ◽

James W. Murrough ◽

Marije aan het Rot ◽

Katherine A. Collins ◽

David L. Reich ◽

...

Keyword(s):

Relapse Prevention ◽

Treatment Resistant ◽

Resistant Depression ◽